| CTRI Number |
CTRI/2023/06/053717 [Registered on: 09/06/2023] Trial Registered Prospectively |
| Last Modified On: |
07/06/2023 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
DO WE REALLY NEED OPIOIDS? - A STUDY DONE IN CHOLECYSTECTOMY PATIENTS. |
|
Scientific Title of Study
|
COMPARISON OF OPIOID FREE ANAESTHESIA AND CONVENTIONAL GENERAL ANAESTHESIA IN PATIENTS UNDERGOING LAPROSCOPIC CHOLECYSTECTOMY – A PROSPECTIVE RANDOMISED CONTROLLED TRIAL |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DR SHWETA DHIMAN |
| Designation |
ASSISTANT PROFESSOR |
| Affiliation |
NORTH DMC MEDICAL COLLEGE AND HINDU RAO HOSPITAL |
| Address |
DEPARTMENT OF ANAESTHESIA. NORTH DMC MEDICAL COLLEGE. MALKA GANJ. DELHI- 110007 MALKA GANJ,DELHI-110007 North DELHI 110029 India |
| Phone |
9650474249 |
| Fax |
|
| Email |
13shweta1990@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR SHWETA DHIMAN |
| Designation |
ASSISTANT PROFESSOR |
| Affiliation |
NORTH DMC MEDICAL COLLEGE AND HINDU RAO HOSPITAL |
| Address |
DEPARTMENT OF ANAESTHESIA, NORTH DMC MEDICAL COLLEGE. DELHI-110007 MALKA GANJ,DELHI-110007 North DELHI 110029 India |
| Phone |
9650474249 |
| Fax |
|
| Email |
13shweta1990@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DR SHWETA DHIMAN |
| Designation |
ASSISTANT PROFESSOR |
| Affiliation |
NORTH DMC MEDICAL COLLEGE AND HINDU RAO HOSPITAL |
| Address |
DEPARTMENT OF ANAESTHESIA, NORTH DMC MEDICAL COLLEGE. MALKA GANJ. NEW DELHI-110007 MALKA GANJ,DELHI-110007 North DELHI 110029 India |
| Phone |
9650474249 |
| Fax |
|
| Email |
13shweta1990@gmail.com |
|
|
Source of Monetary or Material Support
|
| NORTH DMC MEDICAL COLLEGE AND HINDU RAO HOSPITAL |
|
|
Primary Sponsor
|
| Name |
NORTH DMC MEDICAL COLLEGE AND HINDU RAO HOSPITAL |
| Address |
MALKA GANJ, DELHI- 110007 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| NORTH DMC MEDICAL COLLEGE AND HINDU RAO HOSPITAL |
MALKA GANJ, DELHI- 110007 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR SHWETA DHIMAN |
DEPARTMENT OF ANAESTHESIA |
DEPARTMENT OF ANAESTHESIA, NORTH DMC MEDICAL COLLEGE AND HINDU RAO HOSPITAL. MALKA GANJ, DELHI-110007 North DELHI |
9650474249
13shweta1990@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
CONVENTIONAL GENERAL ANAESTHESIA |
premedication with midazolam
1 mg IV and dexamethasone 0.1 mg/kg IV. The anesthesia will be induced using fentanyl 3ug/kg IV, propofol 2.5 mg/kg IV, and vecuronium 0.1 mg/kg IV. Anesthesia will be maintained using isoflurane between 0.5–2% and a continuous infusion of normal saline 10–15 ml/h as placebo.
|
| Intervention |
OPIOID FREE ANAESTHESIA |
premedication with lidocaine 1.5 mg/ kg IV, magnesium sulfate 40 mg/kg (in 100 ml of saline without exceeding 2.5 g), ketamine 25 mg IV and dexamethasone 0.1 mg/kg IV. Induction of general anesthesia will be carried out with propofol 1.5 mg/kg IV and vecuronium 0.1 mg/kg IV. Anesthesia will be maintained using isoflurane between 0.5–2%, and an infusion containing a mixture of magnesium sulfate 40 mg/kg (without exceeding a total dose of 2.5 g/24 h taking note of the induction dose), lidocaine 1.5 mg/kg, ketamine 0.25 mg/kg in 50 ml saline @ 10-15 ml/hr. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1. ASA grade I and II
2. BMI -18-25
3. Undergoing laparoscopic cholecystectomy
4. Written informed consent
|
|
| ExclusionCriteria |
| Details |
• history of allergy to any drug used for OFA or CGA;
• history of alcohol, opioid or drug abuse;
• chronic pain
• psychiatric illness;
• patients undergoing surgery with planned regional anesthesia,
• patients with iatrogenic surgical complications such as bowel, ureter or bladder injuries.
• Duration of surgery exceeding 90 minutes.
• pregnancy
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| the intraoperative need to administer opioids for adequate intraoperative analgesia. |
1) INTRAOPERATIVE
2) POSTOPERATIVE TILL 48 HRS AFTER THE SURGERY |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Occurrence of intra-operative complications e.g. hypotension, hypertension, tachycardia and bradycardia.
2. Mean alveolar concentration (MAC in %) of isoflurane used in both groups.
3. Pain intensity (assessed using the Numerical Rating scale)
4. Need for opioids for pain relief within the first 48 h of surgery;
5. Patient satisfaction (assessed on the Quality of Recovery-40 [QoR-40] questionnaire) at 24 h and 48 h postoperation
|
intra-operative & post operative period (24 & 48 hrs) |
|
|
Target Sample Size
|
Total Sample Size="70" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
03/07/2023 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NONE YET |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [13shweta1990@gmail.com].
- For how long will this data be available start date provided 01-05-2024 and end date provided 01-05-2050?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
|
Brief Summary
|
Opioid free anaesthesia is a technique of providing anaesthesia by combining intravenous administration of a combination of non opioid agents to produce adequate intraoperative analgesia, hypnosis, sympatholysis and pain free awakening. Although opioid analgesics have been the mainstay of conventional general anaesthesia due to their analgesic effect, they are also associated with respiratory depression, gastrointestinal symptoms, urine retention, psychological deficiencies, inflammation modulation & immune depression. To the best of our knowledge, there is paucity of comprehensive data on the feasibility and effectiveness of opioid free anaesthesia in laproscopic surgeries. hence we propose this study to report on the feasibility, efficacy and quality of recovery with an adapted opioid free anaesthesia protocol in subjects undergoing elective laproscopic cholecystectomy. |